Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-07
2011-06-07
Nolan, Jason M (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C560S043000, C562S433000
Reexamination Certificate
active
07956195
ABSTRACT:
The present invention discloses processes for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates.
REFERENCES:
patent: 4841079 (1989-06-01), Urban
patent: 2002/0052370 (2002-05-01), Barber et al.
patent: 2005/0197334 (2005-09-01), Wang et al.
patent: 2005/0250798 (2005-11-01), Dollings et al.
patent: 2006/0051846 (2006-03-01), Ohishi et al.
patent: 2006/0246553 (2006-11-01), Suzuki et al.
patent: 2006/0264457 (2006-11-01), Devasthale et al.
patent: 2008/0096874 (2008-04-01), Birch et al.
patent: WO 9307111 (1993-04-01), None
patent: WO 93/10092 (1993-05-01), None
patent: WO 2006064189 (2006-06-01), None
patent: WO 2006/088944 (2006-08-01), None
patent: WO 2007/098474 (2007-08-01), None
Li, Zhen, Discovery of Potent 3, 5-Diphenyl-1, 2, 4-oxadiazole Sphingosine-1-phosphate-1 (S1P1), Journal of Medicinal Chemistry, (2005) pp. 6169-6173, vol. 48(20).
Mandala et al., “Alteration of Lymphocyte Trafficking by Sphingosine—1-Phosphate Receptor Agonists”, Science, (2002); 296: 346-349.
Jo et al., “S1P1-Selective In Vivo-Active Agonists from High-Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate”. Chemistry & Biology, (2005); 12: 703-715.
Hale et al., “A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists”. J. Med. Chem. (2004); 47: 6662-6665.
Clemens et al., “Synthesis of benzimidazole based analogues of sphingosine—1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists”. Bioorganic & Medicinal Chemistry Letters, (2004); 14: 4903-4906.
Clemens et al., “Synthesis ofPara-Alkyl Aryl Amide Analogues of Sphingosine-1-phosphate: Discovery of Potent S1P Receptor Agonists”. Bioorganic & Medicinal Chemistry Letters, (2003); 13: 3401-3404.
Clemens et al., “Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: Discovery of potent S1P1 receptor agonists”. Bioorganic & Medicinal Chemistry Letters (2005); 1-5.
Aspinall et al.; “BINAP: An industrial approach to manufacture”. Speciality Chemicals Magazine, Jan./Feb. 2005, p. 34-35.
Froestl et al., “Phosphinic Acid Analogues of GABA. 2. Selective, Orally Active GABAb Antagonists”. J. Med. Chem. (1995); 38: 3313-3331.
B. W. Gung, et al., “Total synthesis of two novel brominated acetylenic diols (+)-diplyne C and E: stereoselective construction of the (E)-1-bromo-1-alkene”. Tetrahedron: Asymmetry (2005); 16: 3107-3114.
Grison, et al., “Synthesis of P-chiral enephosphonic acid derivatives”. J. Organomet. Chem. (2002); 662: 83-97.
Prashad, “Phosphonate vs. Phosphinate Elimination During Olefination of Aldehydes” Tetrahedron Letters. (1993); 34: 1585-1588.
Fernando Dilinie P.
Gordon Thomas D.
Hayes Martin E.
Lukin Kirill A.
Wallace Grier A.
Abbott Laboratories
Nolan Jason M
O'Brien Gayle B.
Zwicker Kenneth P.
LandOfFree
Process for the preparation and isolation of the individual... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation and isolation of the individual..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation and isolation of the individual... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2683757